Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04612374 · ClinicalTrials.gov registry record · NA

Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia

A NA study of Misophonia, sponsored by Duke University.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04612374 is a NA study of Misophonia that has completed, run by Duke University. The registered enrollment target is 18 participants, below the 56-participant average among 7 other Misophonia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04612374, a NA study of Misophonia, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Despite increasing recognition of misophonia, there are currently no evidence-based treatments to help those who are suffering. Therefore, the primary purpose of this study is to assess the acceptability, feasibility, and preliminary efficacy of a treatment for misophonia. This study will be conducted in two phases. In the Phase 1, participants will receive a treatment the investigators believe can help manage symptoms of misophonia: The Unified Protocol. This treatment uses evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. After treatment, patients will provide feedback about their experience. The investigators will use this feedback to revise the treatment as indicated. In Phase 2, participants will receive the revised treatment and provide feedback on their experience. Throughout treatment in either phase, participants will provide daily and weekly information about their symptoms. The aims of this study are (1) to explore the acceptability and feasibility of the Unified Protocol for individuals who experience Misophonia and (2) to examine whether this treatment helps reduce symptoms associated with Misophonia.

Conditions Studied

Misophonia

Interventions

  • BEHAVIORAL Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
  • BEHAVIORAL Revised Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-12-21
Est. Completion 2022-08-04
Phase NA

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04612374

The ClinicalTrials.gov registry entry for NCT04612374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 7 other Misophonia trials with a reported enrollment target (68% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Misophonia appearing as the primary indexed condition, and to 2 interventions - of which Unified Protocol for Transdiagnostic Treatment of Emotional Disorders is the first listed.

NCT04612374 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04612374 about?

NCT04612374 is a clinical study titled "Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia". Despite increasing recognition of misophonia, there are currently no evidence-based treatments to help those who are suffering. Therefore, the primary purpose of this study is to assess the acceptability, feasibility, and preliminary efficacy of a treatment for misophonia. This study will be conduct...

What is the current status of trial NCT04612374?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-12-21. Estimated completion is 2022-08-04.

What conditions does trial NCT04612374 study?

This clinical trial studies the following conditions: Misophonia.

What interventions are being tested in trial NCT04612374?

The interventions under investigation include: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (BEHAVIORAL), Revised Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (BEHAVIORAL).

Who is sponsoring clinical trial NCT04612374?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04612374 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Misophonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Misophonia

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.